Tumor Necrosis Factor-α Inhibitor Use Is Not Associated with Lipid Changes in Rheumatoid Arthritis

被引：4

作者：

Bili, Androniki ^{[1
]}

Morris, Stephanie J. ^{[1
]}

Sartorius, Jennifer A. ^{[1
]}

Kirchner, H. Les ^{[1
]}

Antohe, Jana L. ^{[1
]}

Dancea, Sorina ^{[1
]}

Wasko, Mary Chester ^{[1
]}

机构：

[1] Geisinger Hlth Syst, Dept Rheumatol, Danville, PA 17822 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2012年 / 39卷 / 05期

关键词：

RHEUMATOID ARTHRITIS; LIPIDS; TUMOR NECROSIS FACTOR-alpha INHIBITORS; INFLIXIMAB TREATMENT; INSULIN-RESISTANCE; PROFILE; THERAPY; PATTERNS;

D O I：

10.3899/jrheum.111093

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Objective. To determine the association of use of tumor necrosis factor-alpha (TNF-alpha) inhibitors with differences in lipid levels in patients with rheumatoid arthritis (RA). Methods. We studied 807 patients with incident RA to compare differences in lipid levels in TNF-alpha inhibitor users versus nonusers, with adjustment for relevant covariables. Results. TNF-alpha inhibitor use was not associated with differences in levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC), triglycerides, LDL:HDL, or TC:HDL compared to nonusers. Conclusion. Use of TNF-alpha inhibitor was not associated with differences in lipid levels in patients with RA. (First Release April 1 2012; J Rheumatol 2012;39:946-8; doi:10.3899/jrheum.111093)

引用

页码：946 / 948

页数：3

共 18 条

[1]

Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis [J].

Allanore, Y ;

Kahan, A ;

Sellam, J ;

Ekindjian, OG ;

Borderie, D .

CLINICA CHIMICA ACTA, 2006, 365 (1-2) :143-148

[2]

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy [J].

Dahlqvist, SR ;

Engstrand, S ;

Berglin, E ;

Johnson, O .

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (02) :107-111

[3]

Anti-tumour necrosis factor agents and lipid profile: a class effect? [J].

Garces, S. P. ;

Santos, M. J. Parreira ;

Vinagre, F. M. R. ;

Roque, R. M. ;

da Silva, J. A. C. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (06) :895-896

[4]

Kiortsis DN, 2006, J RHEUMATOL, V33, P921

[5]

Patterns and effectiveness of lipid-lowering therapies in a managed care environment [J].

Meyer, JW ;

Schultz, JS ;

O'Donnell, JC ;

Patel, PA ;

Sasane, RM .

VALUE IN HEALTH, 2005, 8 (05) :601-612

[6]

Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody [J].

Nishida, Keiko ;

Okada, Yosuke ;

Nawata, Masao ;

Saito, Kazuyshi ;

Tanaka, Yoshiya .

ENDOCRINE JOURNAL, 2008, 55 (01) :213-216

[7]

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis [J].

Peters, M. J. L. ;

Vis, M. ;

van Halm, V. P. ;

Wolbink, G. J. ;

Voskuyl, A. E. ;

Lems, W. F. ;

Dijkmans, B. A. C. ;

Twisk, J. W. R. ;

de Koning, M. H. M. T. ;

van de Stadt, R. J. ;

Nurmohamed, M. T. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) :958-961

[8]

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis [J].

Popa, Calin ;

van den Hoogen, Frank H. J. ;

Radstake, Timothy R. D. J. ;

Netea, Mihai G. ;

Eijsbouts, Agnes E. ;

Den Heijer, Martin ;

van der Meer, Jos W. M. ;

van Riel, Piet L. C. M. ;

Stalenhoef, Anton F. H. ;

Barrera, Pilar .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) :1503-1507

[9]

Saiki O, 2007, J RHEUMATOL, V34, P1997

[10]

Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis [J].

Seriolo, Bruno ;

Paolino, Sabrina ;

Ferrone, Carmela ;

Cutolo, Maurizio .

CLINICAL RHEUMATOLOGY, 2007, 26 (10) :1799-1800

← 1 2 →